Paper Details
- Home
- Paper Details
Protection of azidothymidine-induced cardiopathology in mice by mildronate, a mitochondria-targeted drug.
Author: GordjushinaValentina, IsajevsSergejs, KalvinshIvars, KlusaVija, KratovskaAina, PupureJolanta, RumaksJuris, SvirskisSimons, TaivansImmanuels, ViksnaLudmila
Original Abstract of the Article :
Azidothymidine, a nucleoside-analogue reverse transcriptase inhibitor (NRTI), is a commonly used antiretroviral drug in AIDS treatment, however its use is limited by severe toxic side effects due to its influence on mitochondria that result in myopathy, particularly affecting the cardiac muscle. We ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1111/j.1742-7843.2006.pto_543.x
データ提供:米国国立医学図書館(NLM)
Protecting the Heart: Mildronate's Potential in Combating Azidothymidine-Induced Cardiopathology
The field of [HIV/AIDS Treatment] faces a critical challenge in managing the [Cardiotoxic Side Effects] of [Azidothymidine], a widely used [Antiretroviral Drug]. This study explores the potential of [Mildronate], a [Mitochondria-Targeted Drug], in mitigating these adverse effects. The researchers investigated the impact of [Mildronate] on [Cardiopathology] induced by [Azidothymidine] in a mouse model. Their findings reveal that [Mildronate] effectively prevented [Morphological Changes] in cardiac tissue, including [Degeneration] and [Inflammation], induced by [Azidothymidine]. This suggests that [Mildronate] could offer a promising therapeutic strategy for protecting against [Azidothymidine]-induced [Cardiotoxicity].
The Promise of Mildronate in Mitigating Cardiotoxicity
The study's results demonstrate the potential of [Mildronate] in safeguarding the heart against [Azidothymidine]-induced damage. The ability of [Mildronate] to prevent [Morphological Changes] in cardiac tissue suggests its effectiveness in combating [Cardiotoxicity]. This discovery has significant implications for [HIV/AIDS Treatment] by potentially minimizing the risk of [Cardiovascular Complications] associated with [Azidothymidine] therapy.
A New Avenue for Protecting the Heart
This research highlights the importance of considering [Mitochondria-Targeted Drugs] as potential solutions for managing [Cardiotoxicity] in [HIV/AIDS Treatment]. The study's findings offer a promising avenue for exploring the use of [Mildronate] in combination with [Azidothymidine] or other [Anti-HIV Drugs], potentially improving the safety profile of [Antiretroviral Therapy] and enhancing the long-term health of individuals living with HIV.
Dr.Camel's Conclusion
This research is a testament to the power of [Mitochondria-Targeted Drugs] in safeguarding the heart. It underscores the importance of continuing research in this area to develop safer and more effective treatment strategies for [HIV/AIDS]. Like a desert oasis, [Mildronate] offers a glimmer of hope in mitigating the [Cardiotoxic] effects of [Azidothymidine], potentially improving the quality of life for individuals living with HIV.
Date :
- Date Completed 2007-02-15
- Date Revised 2016-11-24
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.